Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.

Secretory leukocyte proteinase inhibitor (SLPI) and alpha1-proteinase inhibitor (alpha1(PI)) cannot fully explain the total neutrophil elastase (NE) inhibitory capacity detected in bronchoalveolar lavage (BAL) fluid, suggesting the existence of other NE inhibitor(s). In the present study, we measured the concentrations of elafin, a newly described, low-molecular-weight serine proteinase inhibitor, SLPI, and alpha1(PI) in BAL fluids from eight healthy subjects, 13 asymptomatic farmers, seven farmers with active farmer's lung (FL), and seven farmers with previous (Ex) FL. In addition to SLPI and alpha1(PI), elafin was present in BAL fluids from control subjects and asymptomatic farmers, 13 (7-31) and 12 (7-67) mmol/mol of albumin (median and range) respectively. Elafin concentration increased significantly to 105 (38-207) mmol/mol of albumin in farmers with active FL and was also elevated in farmers with Ex FL. Elafin levels were highly correlated with lung inflammatory cell numbers, especially lymphocytes, and the decrease in single-breath diffusion capacity (DLCO). Elafin and SLPI were linked to yet uncharacterized proteins in BAL fluids. In conclusion, elafin is a constituent of BAL fluid from normal subjects and is found in enhanced concentrations in FL and in farmers with lymphocytic alveolitis. This suggests that elafin may play a role in lung homeostasis and inflammation.

[1]  M. Jordana,et al.  Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. , 1994, American journal of respiratory cell and molecular biology.

[2]  C. Boudier,et al.  Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor. , 1994, The Biochemical journal.

[3]  R. Braun,et al.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.

[4]  O. Vandenplas,et al.  Bronchoalveolar lavage immunoglobulin A and G and antiproteases correlate with changes in diffusion indices during the natural course of pulmonary sarcoidosis. , 1994, The European respiratory journal.

[5]  R. Crystal,et al.  Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[6]  K. Yamanishi,et al.  Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. , 1994, The Journal of investigative dermatology.

[7]  R. Stockley,et al.  Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. , 1994, Thorax.

[8]  G. Leikauf,et al.  Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. , 1993, The American journal of physiology.

[9]  C. Vogelmeier,et al.  Activation of blood neutrophils in acute episodes of farmer's lung. , 1993, The American review of respiratory disease.

[10]  B. Wieringa,et al.  SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. , 1993, The Journal of biological chemistry.

[11]  T. Ogura,et al.  Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. , 1993, The Tokushima journal of experimental medicine.

[12]  J. Sallenave,et al.  Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. , 1993, American journal of respiratory cell and molecular biology.

[13]  J. Sallenave,et al.  Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. , 1993, American journal of respiratory cell and molecular biology.

[14]  J. Aubert,et al.  Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase. , 1992, The Biochemical journal.

[15]  W. Gray,et al.  Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. , 1991, The Journal of biological chemistry.

[16]  O. Wiedow,et al.  Elafin is a potent inhibitor of proteinase 3. , 1991, Biochemical and biophysical research communications.

[17]  J. Schröder,et al.  Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. , 1990, The Journal of biological chemistry.

[18]  T. Stijnen,et al.  Antileukoprotease-containing bronchiolar cells. Relationship with morphologic disease of small airways and parenchyma. , 1989, The American review of respiratory disease.

[19]  B. Châtelain,et al.  Antiproteases are increased in bronchoalveolar lavage in interstitial lung disease. , 1988, The European respiratory journal.

[20]  J. Tournier,et al.  The elastase inhibitory capacity and the alpha 1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects. , 1987, Biological chemistry Hoppe-Seyler.

[21]  R. Stockley,et al.  Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. , 1987, Clinical science.

[22]  R. Stockley,et al.  Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. , 1985, Analytical biochemistry.

[23]  M. Mccarthy,et al.  A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. , 1985, Journal of immunological methods.

[24]  C. Meijer,et al.  Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung. , 1983, Thorax.

[25]  F. N. David,et al.  Principles and procedures of statistics. , 1961 .

[26]  S. Twining.  Regulation of proteolytic activity in tissues. , 1994, Critical reviews in biochemistry and molecular biology.

[27]  J. Sallenave,et al.  Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. , 1992, Biological chemistry Hoppe-Seyler.

[28]  R. Crystal,et al.  The Lung: Scientific Foundations , 1991 .